Who planning commission: cancel the drug income is not affected by the big bonus hospital 
 
 
Source: China's news 

    Beijing, May 22 (xinhua) sun zhigang, vice minister of the national health and family planning commission said today, from the current reform of policy design and has been in the public hospital reform pilot city and pilot in the hospital, the hospital after canceling drug addition, income is not affected by the large hospital.
 
    Sun zhigang in the scio policies of the state council routine briefing held today to make the above statement, the briefing by the national health and family planning commission, deputy director of sun zhigang, deputy director of the state administration of traditional Chinese medicine 闫树江 introduced fully implemented comprehensive reform in public hospitals at the county level, public hospital comprehensive reform pilot cities, traditional Chinese medicine health service development plan (2015-2020), we will deepen reform of the medical and health system in 2015, the key work, etc.
 
    The media asked, the influence on the reform of hospital income, especially for the influence of foreign drug manufacturers. Because now the reform will reduce prescription drug addition, what is the effect of income for the hospital? For drug makers and what is the effect? Especially for the foreign drug manufacturer what effect?
 
    Sun zhigang said, advancing the reform of public hospitals now, break public hospital profit mechanism, establish a new operating mechanism, this new mechanism is to maintain public welfare, to mobilize enthusiasm, ensuring the sustainable operation mechanism. Breaking mechanism of profit-seeking first is to break to medicine in the medical, to cancel the drug addition, cancel the drug addition earnings will certainly affect the hospital drugs, cancel the drug addition influence income part of the hospital after will increase by the adjustment of medical service prices, government subsidies, reduce hospital operating costs to bear.
 
    At the same time we for hospital expenses for drug storage, safekeeping, loss is compensated for in hospital operation cost. Therefore, from the current reform of policy design and has been in the public hospital reform pilot city and pilot in the hospital, the hospital after canceling drug addition, income is not affected by the large hospital.
 
    Sun zhigang said about the impact on foreign companies, foreign pharmaceutical factory production of medicines, buy now will still be buying after the hospital reform, not to buy, the key is how to buy medicine, procurement, with what kind of price under the state council recently issued by the "about perfecting the public hospital drug centralized purchasing guidance", summed up for so many years of experience and lessons, and determine the principle of "four to" :
 
    First, to help break the mechanism of public hospitals to medicine cure, promote the reform of public hospitals. Second, to reducing drug prices artificially high, reduce the burden of health care and patient. Third, to help curb corruption in the field of drug distribution. Fourth, to promote pharmaceutical production and circulation enterprise resource optimization reorganization, healthy development.
 
    Sun zhigang said, therefore, in the reform has been considered in the interests of the pharmaceutical production and circulation enterprises is not only the interests of the foreign companies, including China, the interests of the Chinese pharmaceutical enterprises, the hospital drug procurement is divided into five classes of drugs, the categorized procurement.
 
    The first category is a patent medicine, the market competition is more fully, more enterprises production, clinical use of drugs, implement international general, in the provinces unit centralized bid procurement, but this method and the public hospital public bidding way is different.
 
    Several main characteristics: the first is called production enterprises, circulation enterprises bidding. Quantity and price for unity, hook, the double envelope system, with a number for a relatively low price, this is in line with the economic law, is the international general practice in many developed countries for purchasing drugs.
 
    The second category is the part of the patent drugs, exclusive production of drugs for procurement negotiations, negotiations in the province, or a provincial unite to negotiate, the unite to negotiate a certain aspect, also with the quantity of purchasing for a cheaper price.
 
    "We are now buying patent medicine and exclusive production of drug prices are artificially high generally, China's demand is very big, with such a large market demand, we hope to be able to get through negotiations, in exchange for a lower and reasonable price. It is also a common international practice, when I was in Australia, New Zealand visit last month, they are countries, patent medicine to negotiate foreign drug firms, and then cut down the price. Now we are going to build a participating, open and transparent negotiation mechanism, make patent medicine and exclusive production of the price of the drug to down to a reasonable range." Sun zhigang said.
 
    The third kind is the necessary for clinical drugs, dosage is small, the market supply shortage, the tender by the country fixed-point production, ensure the reasonable profit of the enterprise, make necessary for clinical, small dosage of cheap drugs don't withdraw from the market because of market factors. For especially generic drugs and drugs commonly used, urgent rescue, basic infusion, small clinical dosage of drugs and drugs commonly used low price, etc., realize centralized hanging net, to purchase by the hospital based on the specific range determined by various provinces.
 
    Sun zhigang said that for special drugs still maintain the existing procurement method, five kind procurement method is implemented. These five kind procurement method for both foreign and domestic production enterprises is fair and equal, we won't be alone for foreign drugs out a way to everyone equal treatment, what kind of purchase, what kind would have attended either competition, or to negotiate. Drug purchase way to reform is in line with international practice, in line with the economic law, is advantageous for the pharmaceutical producing enterprises, to encourage drug circulation order specifications up step by step.
 
 
 
The original link: http://www.jkb.com.cn/news/industryNews/2015/0522/369924.html